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As a segment of ongoing surveys and with the aim of expansion of environmentally benign processes, a series of 
biologically varied type of substituted 2-amino-3-cyano-4H-pyrans and pyran-annulated Scaffolds have been synthesized by 
tandem Knoevenagel-cyclocondensation of aldehydes, malononitrile, and C-H-activated acidic compounds in aqueous ethanol 
in the presence of Ag/TiO2 nano-thin films as an eco-friendly, recyclable, and, robust catalyst at 60°C. The salient features of 
this protocol are mild reaction conditions, producing target compounds in high yields, short reaction times, high atom economy, 
eco-friendly catalyst, easy isolation of products and no column chromatographic separation. Also, it is observed that the catalyst 
is highly stable during the reaction and several reuse times without observable loss in catalytic performance. 
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Ag/TiO2 nano-thin film 
4H-Pyran and 4H-pyran-annulated and their analogues 
constitute a substantial family of scaffolds distributed 
throughout nature occurring1-3 with a wide range of 
remarkable biological activities that subtend anti-
inflammatory4, antimalarial5,6, anticancer7, cytotoxic8, 
antimicrobial9, antihyperglycemic10, anti-HIV11-13 and 
antidyslipidemic10 apart from being identified as anti-
neurodegenerative perturbations such as Huntington’s 
disease, Alzheimer’s, Parkinson disease14, etc. In 
particular, 4H-pyran moiety is still being used in the 
treatment of diverse ailments, like asthma, ischemia, 
hypertension, and urinary incontinence15-19. Some of 
the naturally occurring bioactive pyran-annulated 
heterocyclic framework displaying a various type of 
pharmaceutical potentials have been illustrated 
in Figure 1 20-25. Several approaches have been 
designed for the synthesis of 4H-pyran derivatives like 
trisodium citrate26, H6P2W18O62ꞏ18H2O
 27, (S)-proline28, 




heteropolyacids35, basic ionic liquid36, ionic liquid
based on magnetic carbon37, 2,2,2-trifluoroethanol38,
DBU39, CaCl2
 40 and urea41 as catalysts.
In recent times, emergent awareness regarding 
ecological safety and global warming has created 
universal interest as to the benefit of renewable sources 
and decrement of wastage. In this regards, the use of 
green solvents and catalyst in all phases of chemical 
construction are considered substantial tools from the 
sight of green chemistry protocols42-44. Worldwide 
request for environmentally friendly chemical 
processes, require the design of reclaimable catalysts 
that provides a practical, inexpensive, operationally 
straightforward and high yielding approach. From this 
aspect, nanotechnology has presented nanocatalysts 
with higher catalytic activity owing to their large 
surface area, recoverability, small size, and catalyst 
loading capacity, distinctive electronic, magnetic, 
optical and thermal properties45-47. Furthermore, the 
active sites on their surfaces are easily available by 
reactants. Recently, organic synthesis catalyzed by 
metal/metal oxide nanoparticles has obtained notable 
importance. 
Nowadays, TiO2 nanoparticles have appeared as a 
noteworthy multi-functional substance with unique 
attributes like high stability, long lasting, and the safe 
and broad-spectrum antibiotic48. In particular, TiO2 
nanoparticles have been the center of notice owing to 
various applications49 including optical films for 
photocatalysts50, fuel cells51, lithium-ion batteries52, 




sensors53, and semiconductor materials for 
photochemical virtues54,55. 
In addition, TiO2 nanoparticles have been exerted as 
an eco-friendly catalyst for the synthesis of compound 
libraries of medicinal scaffolds55. Correction of 
nanocrystalline TiO2 films by metal doping is 
progressively being considered to enlarge the 
photocatalytic proficiency due to increased electron 
traps and decreased TiO2 bandgap
56,57. Noble metal 
nanoparticles like silver are recognized to depict 
catalytic, electric, and special optical characters. 
Accordingly, the infusion of nanoparticles Ag to 
mesoporous TiO2 substrate motifs could be exerted as 
antibacterial materials for medical utilizations and in the 
water therapy field processes58. 
In view of these important points and continuing our 
efforts on the development of green catalytic manners for 
substantial organic conversions59-67, we aim to report a 
facile, fast and high yielding synthesis of 2-amino-3-
cyano-7,8-dihydro-4H-chromen-5(6H)-ones 6, 7 and 8,  
2-amino-3-cyano-pyrano[3,2-c]chromen-5(4H)-ones 10, 
11 and 12, 1H-pyrano[2,3-d]pyrimidine-2,4(3H,5H)-
diones 14 and 2-amino-7-hydroxy-4H-chromene-3-
carbonitriles 16 by three-component reaction of aldehyde, 
malononitrile and C−H-activated acids in water medium 
at 60°C in the presence of Ag ion doped in TiO2 lattice 
was occupied as nontoxic, cheap, and readily accessible 
heterogeneous catalysts (Scheme I). Ag-TiO2 
nanocomposite films were deposited on insides of beakers 
by spray pyrolysis technique. 
 
Result and Discussion 
To optimize the reaction conditions, we tentatively 
considered the reaction between benzaldehyde  
(1.0 mmol), malononitrile (1.0 mmol) and dimedone 
(1.0 mmol) as a model reaction using Ag/TiO2 nano-thin 
films as a green catalyst for the synthesis of 2-Amino-3-
cyano-7,8-dihydro-4H-chromen-5(6H)-ones (Scheme I). 
At the outset, a test reaction was accomplished in the 
absence of the catalyst at 40°C and offered only 37 % 
yield of the desired product, as shown in (Table I, entry 
1). Then, a brief screening of diverse solvents were 
afforded (Table I). These studies revealed that the rate 
2:1 H2O/ EtOH is better than other rates. Finally, to 
investigate the efficacy of reaction temperature, the 
model reaction was done at different temperatures. The 
yield growth to 93% when the reaction was carried out 
at 60 °C temperature (Table I, entry 8). Accordingly, the 
optimization of reaction conditions was established as 
indicated in Table I and entry 8. 
After establishing the most desirable situations, to 
study the generality as well as the efficacy of our enlarged 
strategy, a various aryl aldehydes, Isatine and 
Acenaphthoquinone 1 were reacted with malononitrile 4 
and dimedone 5; all of them underwent the reaction 
furnishing the desired 2 -Amino-3-cyano-7,8-dihydro-4H-
chromen-5(6H)-ones (6-8) (Table II, entries 1-13) in good 
to excellent yields (80-93%). To our delight, the reactions 
endeavored by replacing dimedone (5) with  
4-hydroxycoumarin (9) (Scheme I) also underwent 
favored condensation to afford the desired 2-Amino-3-
cyano-pyrano[3,2-c]chromen-5(4H)-ones (10-12) 
(Table II, entries 14-26) in good to excellent yields (80-
93%) under the analogous reaction conditions, we 
endeavored to developed the present strategy using 
barbituric acid and its N, N-dimethyl derivative (13) and 
resorcinol (15) as varying C-H-activated acids. These C-
H activated acids underwent reactions as well as with 
diverse aryl aldehydes and malononitrile under the 
analogous reaction conditions (Scheme I). 
 
 
Figure 1 — Some drugs containing pyran core 
 




The desired products, 1H-pyrano-[2,3-d]pyrimidine-
2,4(3H,5H)-diones (14) (Table II, entries 27-42)and  
2-amino-7-hydroxy-4H-chromene-3-carbonitriles (16) 
(Table II, entries 43-51) were obtained in good to 
excellent yields (80-94%) with adequate time under 
Ag/TiO2 nano-thin films-catalysis. 
A schematic mechanism, representing the role of 
Ag/TiO2 nano-thin films in the tandem synthesis of 
pyran-annulated heterocycles is suggested in Scheme II. 
Initially, Knoevenagel condensation between aldehyde 2 
and malononitrile 4 is accomplished to give  
α-cyanocinnamonitrile A. Next, C-H activated acids 5 
C-alkylation carries out an intermediate B which 
subsequently cyclizes via nucleophilic attack of O atom 
on the cyano moiety conformance to protonation and 





















































































Scheme I — Ag/TiO2 catalyzed one-pot synthesis of functionalized 2-amino-3-cyano-4H-pyrans and pyran-annulated heterocyclic 
scaffolds 
 











Entry Temperature (°C) Catalyst/Solvent Time (min) Isolated Yield (%) 
1 40 EtOH/- 24h 37 
2 40 EtOH/Cat 90 66 
3 40 Cat/ H2O: EtOH (1:1) 75 73 
4 40 Cat/ H2O: EtOH (2:1) 70 78 
5 40 Cat/H2O 75 75 
6 r.t Cat/ H2O: EtOH (2:1) 24h 20 
7 50 Cat/ H2O: EtOH (2:1) 40 90 
 























































































Entry R R1 Product Time (min) Yield a (%) m.p. (°C) (Lit. Ref.) 
1 H − 6a 20 93 230-232 (225-227) (Ref. 38) 
2 2-Cl − 6b 25 83 210-212 (215-217) (Ref. 41) 
3 4-Cl − 6c 15 90 208-210 (212-214) (Ref. 41) 
4 2-NO2 − 6d 35 89 227-230 (222-223) (Ref. 28) 
5 3-NO2 − 6e 30 90 210-213 (205-208) (Ref. 26) 
6 4-NO2 − 6f 20 93 183-185 (183-185) (Ref. 41) 
7 4-Me − 6g 30 85 208-210 (205-206) (Ref. 41) 
8 4-OMe − 6h 30 87 205-207 (200-202) (Ref. 39) 
9 2,3-diOMe − 6i 40 80 218-220 (214-216) (Ref. 65) 
10 4-OH- 3-OMe − 6j 45 82 228-230 (226-231) (Ref. 64) 
11 4-OH  − 6k 55 80 206-208 (202-204) (Ref. 39) 
12 Isatine − 7 45 87 296-298 (291-293) (Ref. 32) 
13 Acenaphthoquinone − 8 50 82 268-270 (268-270) (Ref. 68) 
14 H − 10a 25 90 258-260 (256-258) (Ref. 38) 
15 2-Cl − 10b 35 86 275-276 (275-277) (Ref. 66) 
16 4-Cl − 10c 25 93 263-265 (262-264) (Ref. 41) 
17 2,4-diCl  − 10d 45 80 258-260 (255-257) (Ref. 27) 
18 3-NO2 − 10e 35 85 260-262 (254-256) (Ref. 41) 
19 4-NO2 − 10f 30 93 255-257 (258-260) (Ref. 41) 
20 4-Me − 10g 40 87 253-255 (257-259) (Ref. 41) 
21 2-F − 10h 40 90 222-224 (220-223) (Ref. 64) 
22 2,3-diOMe − 10i 60 85 214-216 (216-218) (Ref. 66) 
23 4-OH-3-OMe − 10j 40 87 254-257 (255-257) (Ref. 27) 
24 4-OH − 10k 40 83 260-263 (262-264) (Ref. 41) 
25 Isatine − 11 55 90 275-277 (281-282) (Ref. 32) 
26 Acenaphthoquinone − 12 60 85 297-299 (>300) (Ref. 68) 
28 2-Cl H 14b 35 85 218-220 (213-215 ) (Ref. 69) 
29 3-Cl H 14c 30 87 260-263 (266-268 ) (Ref. 40) 
(Contd.) 




Ag/TiO2 nano-thin films entrusted on the insides of 
beakers could be easily resumed without observable 
damages in catalytic proficiency. This catalytic system 
was checked for the condensation of benzaldehyde, 
malononitrile, and dimedone as a model in ten catalytic 
runs, and no sensible shift in activity was observed that all 
derivatives of each reaction were synthesized from only 
one beaker coated TiO2 thin film as shown in Figure 2. 
Experimental Section 
 
Materials and Methods 
Melting points and IR spectra of all compounds 
were determined using an Electro thermal 9100 
apparatus and FTIR-JASCO-460 plus spectrometer. 
The 1H NMR spectra of known compounds were 
recorded on a Bruker DRX-300 and 400 Avance 
instrument in DMSO-d6 and CDCl3 at 300 and 
Table II — Synthesis of pyran-annulated heterocycles. 
 
Entry R R1 Product Time (min) Yield a (%) m.p. (°C) (Lit. Ref.) 
30 4-Cl H 14d 20 93 238-240 ( 236-238) (Ref. 41) 
31 2,4-diCl H 14e 40 85 240-242 ( 241-242) (Ref. 29) 
32 3-NO2 H 14f 30 87 269-271 (264-265 ) (Ref. 40) 
33 4-NO2 H 14g 25 94 236-238 (235-236) (Ref. 69) 
34 4-CN H 14h 20 88 243-245 (240-241 ) (Ref. 29) 
35 H CH3 14i 25 92 219-221 ( 218-220) (Ref. 31) 
36 4-F CH3 14j 25 94 228-230 (227-228 ) (Ref. 31) 
37 4- Cl CH3 14k 20 93 203-205 (206 ) (Ref. 31) 
38 4-Br CH3 14l 20 92 231-233 ( 235) (Ref. 31) 
39 4-NO2 CH3 14m 25 90 210-212 (217-219 ) (Ref. 31) 
40 4-Me CH3 14n 30 87 215-218 ( 217-218) (Ref. 31) 
41 2-F CH3 14o 30 87 236-237 ( 238-239) (Ref. 31) 
42 H − 16a 60 92 229-231 (232-233 ) (Ref. 33) 
43 4-Cl − 16b 45 90 162-163 ( 162-163) (Ref. 33) 
44 2-F − 16c 50 87 200-201 ( 200-202) (Ref. 33) 
45 4-F − 16d 45 92 186-187 ( 186-187) (Ref. 33) 
46 4-Me − 16e 60 85 181-182 ( 182-183) (Ref. 33) 
47 4-OMe − 16f 55 88 111-114 (111-112 ) (Ref. 33) 
48 Thiophene-2 − 16g 60 89 188-190 (204-205 ) (Ref. 37) 
49 Furan-2- − 16h 60 90 186-189 (189-191) (Ref. 37) 
50 Naphtalene-2- − 16i 70 80 228-232 ( 231-232) (Ref. 36) 
 
 
Scheme II — The proposed mechanism for the synthesis 4H-Pyran and 4H-pyran-annulated heterocycles 
 




400MHz. The crystal structure was examined using 
Bruker D8-advanced diffractometer with CuKα 
radiation in the 10<2θ<70 range, the surface 
morphology was analyzed using of DME- SPM (2.4.2.1) 
AFM and optical spectroscopy was performed by  
T80- PG instrument double beam spectrophotometer 
and the Photoluminescence analysis (PL) was performed 
by Perkin Elmers LS-3. All the chemicals were provided 
from chemical producer Merck (Darmastadt, Germany) 
and Fluka (Buchs, Switzerland) and used without further 
purification. 
 
General procedure for preparation of Ag/TiO2 
nano-thin films 
For the preparation of spray precursor, titanium 
isopropoxide (TTIP) was applied as precursor of Ti and 
Acetyl Acetone (AcAc) along with Ethanol 6% used as 
a solution. The rate of molar composition of TTIP: 
AcAc in the spray solution is 1:2. The solution was 
magnetically stirred for 30 minutes and then silver 
nitrate was added as the source of Ag in a molar ratio of 
Ag: TTIP equal to 3:10. In continuation, the final 
solution was stirred for 30 min. This solution was 
sprayed onto well cleaned preheated substrates. Before 
spraying, the microscope glass slides were washed by 
substrate cleaner and after drying with compressed air, 
they were put in an ultrasonic cleaner containing acetone 
for 10 minutes. Catalyst characterization Optical, 
morphological, and structural properties of catalyst were 
investigated by XRD, AFM, spectrophotometry and 
photoluminescent spectroscopy. The outcomes of this 
research were mentioned in supporting information. 
 
General procedure for the synthesis of 2-amino-3-
cyano-7,8-dihydro-4H-chromen-5(6H)-ones 4 and 2-
amino-3-cyano-pyrano[3,2-c]chromen-5(4H)-ones 
A mixture of aromatic aldehydes (1.0 mmol), 
malononitrile (1.0 mmol) was stirred in EtOH/H2O  
(3 mL) in presence of Ag/TiO2 nanocomposite films 
which have been deposited inside beakers at RT for 
about 20 min. After that, C-H activated acid (5)  
(1.0 mmol) was added to the stirred reaction mixture, 
and the stirring was continued for the appropriate time 
at 60°C. The progress of the reaction was monitored 
by thin layer chromatography (TLC). Finally, the 
reaction mixture was cooled to RT, and then water 
and ethanol (5 mL) were added to the mixture of 
reaction and filtered to separate the product 6. Finally, 
the crude product was recrystallized from ethanol to 
afford the pure product. The structure of some 
purified pyran- annulated heterocyclic scaffold was 
confirmed by analytical as well as spectral studies 
including FT-IR and 1H NMR. 
 
Spectral data for the selected compounds 
2-Amino-5,6,7,8-tetrahydro-7,7-dimethyl-5-oxo-4-
phenyl-4H-chromene-3-carbonitrile, 6a: White solid. 
m.p. 230-232°C. IR (KBr): 3395, 3323, 2641, 2199, 
1680, 1240 cm−1; 1H NMR (400 MHz, CDCl3): δ 1.07 
(s, 3H), 1.14 (s, 3H), 2.23 (d, 1H, J = 16.4 Hz), 2.27  
(d, 1H, J = 16.4 Hz), 2.48, (s, 2H), 4.43 (s, 1H), 4.55  
(s, 2H), 7.2, 7.3 (m, 5H). 
2-Amino-5,6,7,8-tetrahydro-4-(4-nitrophenyl)-7,7-
dimethyl-5-oxo-4H-chromene-3-carbonitrile, 6f: 
Yellow solid. m.p. 182-184°C. IR (KBr): 3375,3324, 
3182, 2956, 2187, 1674, 1246 cm−1; 1H NMR (300 
MHz, DMSO-d6): δ 0.95 (s, 3H, CH3), 1.027 (s, 3H, 
CH3 ), 2.12 (d, 1H, J = 16.0 Hz), 2.27 (d, 1H, J = 16.0 
Hz), 2.51 (d, 2H J = 10.0 Hz), 4.36 (s, 1H,CH), 7.19  
(s, br, NH2), 7.44 (d, 2H, Ar, J = 8.0 Hz), 8.16 (d, 2H, 
Ar, J = 8.0 Hz). 
 
 
Figure 2 — Recyclability of the catalyst in the synthesis of 4a over 10 runs 
 






White solid. m.p. 210-212°C. IR (KBr): 3331, 3318, 
2962, 2190, 1680, 1246 cm−1; 1H NMR (400 MHz, 
DMSO-d6): δ 1.08 (s, 3H), 1.12 (s, 3H ), 2.21 (d, 1H J 
16.4), 2.24 (d, 1H, J = 16.4 hz), 2.30 (s, 3H), 2.46 (s, 2H), 
4.38 (s, 1H), 4.57(s, 2H), 7.10 (d, 2H, J = 8 Hz), 7.14 (d, 




Yellow solid. m.p. 205-207°C. IR (KBr): 3465, 3320, 
2955, 2190, 1676, 1247 cm−1; 1H NMR (300 MHz, 
DMSO-d6): δ 0.95 (s, 3H, CH3), 1.04 (s, 3H, CH3 ), 
2.09 (d, 1H, J = 18.0 Hz), 2.25 (d, 1H, J = 18.0 Hz), 
3.37 (d, 2H, J = 6.0 Hz), 3.72 (s, 3H, OCH3), 4.13  
(s, 1H, CH), 6.85 (d, 2HAr, J = 8.0 Hz), 6.97 (br, NH2), 




Orange solid. m.p. 206-208°C. IR (KBr): 3285, 3160, 
2960, 2185, 1675, 1209 cm−1; 1H NMR (400 MHz, 
CDCl3): δ 1.05 (s, 3H, CH3), 1.12 (s, 3H, CH3),  
2.20-2.29 (dd, 2H, J = 16.0 Hz, J = 20.0 Hz), 2.41-
2.50 (dd, 2H, J = 16.0 Hz, J = 20.0 Hz), 4.36 (s, 1H, 
CH), 4.53(s, 2H, NH2), 5.26 (s, 1H, OH), 6.71-7.28 
(m, 4H, Ar). 
2-Amino-4,5-dihydro-4-(phenyl)-5-oxopyrano[3,2-
c]chromene-3-carbonitrile, 10a: White solid. m.p. 258-
260°C. IR (KBr): 3377, 3284, 2922, 2189, 1708, 1380 
cm−1; 1H NMR (400 MHz, DMSO-d6): δ 4.57 (s, 1H, 
CH), 6.70 (s, 2H, NH2) 7.26-8.00 (m, 11H, Ar, NH2). 
 
2-Amino-4,5-dihydro-4-(3-nitrophenyl)-5-oxo-
pyrano[3,2-c]chromene-3-carbonitrile, 10e: White 
solid. m.p. 260-262°C. IR (KBr): 3402, 3322, 2202, 
1703, 1380 cm−1; 1H NMR (400 MHz, DMSO-d6): δ 
4.75 (s, 1H, CH), 7.48-8.16 (m, 9H, Ar, NH2). 
 
2-Amino-4,5-dihydro-4-(2-fluorophenyl)-5-oxo-
pyrano[3,2-c]chromene-3-carbonitrile, 10h: White 
solid. m.p. 220-223°C. IR (KBr): 3400, 3320, 2100, 
1750, 1665, 1609, 1528, 1375 cm−1; 1H NMR (400 
MHz, DMSO-d6): δ 4.75 (s, 1H, CH), 7.10-8.39 




bonitrile, 14f: White solid. m.p. 269-271°C. IR (KBr): 
3415, 3311, 3203,3102, 2951, 1710,1536, 1280 cm−1; 
1H NMR (300 MHz, DMSO-d6): δ 4.50 (s, 1H, CH), 
7.28 (s, 2H, NH2), 7.62 (t, 1H, J = 7.8, Ar), 7.76 (d, 
1H, J = 7.2, Ar), 8.03-8.13 (m, 2H, Ar), 11.12 (br, 1H, 
NH), 12.17 (br, 1H, NH). 
7-Amino-5-(4-nitrophenyl)-2,4-dioxo-1,3,4,4a,5,8a-
hexahydro-2H-pyrano[2,3-d]pyrimidine-6-car-
bonitrile, 14g: White solid. m.p. 236-238°C. IR 
(KBr): 3360, 3183, 2856, 2196, 1720,1348, 1282 
cm−1; 1H NMR (300 MHz, DMSO-d6): δ 4.48 
(s,1H,CH), 7.38 (s, 2H, NH2) 7.60-8.16 (m, 4H, Ar), 




dine-6-carbonitrile, 14p: White solid. m.p. 236-237°C. 
IR (KBr): 3360, 3183, 2856, 2196, 1720,1348, 1282 
cm−1; 1H NMR (300 MHz, DMSO-d6): δ 3.10 (s, 3H, 
CH3), 3.39 (s, 3H, CH3), 4.65 (s, 1H, CH), 7.11-7.39 
(m, 6H, Ar, NH2). 
 
2-Amino-7-hydroxy-4-phenyl-4H-chromene-3- 
carbonitrile, 16a: White solid. m.p. 229-231°C. IR 
(KBr): 3360, 3183, 2856, 2196, 1720,1348, 1282 
cm−1; 1H NMR (300 MHz, DMSO-d6): δ 4.63 (s, 1H, 
CH), 6.42 (d, 1H, J = 2.1 Hz, CH), 6.50 ( dd, 1H, 
J = 2.4 Hz, CH), 6.82 (d, 1H, J = 8.7 Hz, CH), 6.88 ( 
s, 2H, NH2), 7.17-7.34 (m, 5H, Ar), 9.70 (s, 1H, OH). 
 
2-Amino-4-(2-fluorophenyl)-7-hydroxy-4H-chro-
mene-3-carbonitrile, 16c: White solid. m.p.  
200-201°C. IR (KBr): 3360, 3183, 2856, 2196, 1720, 
1348, 1282 cm−1; 1H NMR (300 MHz, DMSO-d6):  
δ 4.71 (s, 1H, CH), 6.45 (d, 1H, J = 2.4, CH), 6.53 
(dd, 1H, J = 2.4 Hz, CH), 6.85 (d, 1H, J = 8.4 Hz, 
CH), 6.95-7.40 (m, 6H, Ar, NH2), 9.76 (s, 1H, OH). 
 
Concusion 
Within this article, we have constructed a series of 
variety pharmaceutically functionalized 4H-pyrans and 
pyran-annulated skeletons via easy, facile, green, and 
conveniently practical procedure in the presence of 
Ag/TiO2 nano-thin films as an eco-compatibility 
catalyst, through one-pot tandem Knoevenagel-
cyclocondensation of aldehydes, malononitrile, and 
C−H-activated acids in aqueous ethanol at 60 °C. Mild 
reaction situations, high yields, lack of boring separation 
procedures and high atom-economy, moreover the 
application of cheap and the reusability of the catalyst 
are the key advantages of the present procedure. 
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